<VariationArchive RecordType="classified" VariationID="7040" VariationName="NM_004562.2(PRKN):c.8-?_171+?del" VariationType="Deletion" Accession="VCV000007040" Version="6" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-03-18" DateCreated="2017-09-10" MostRecentSubmission="2022-12-31">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="22079" VariationID="7040">
      <GeneList>
        <Gene Symbol="PRKN" FullName="parkin RBR E3 ubiquitin protein ligase" GeneID="5071" HGNC_ID="HGNC:8607" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6q26</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="161347417" stop="162727766" display_start="161347417" display_stop="162727766" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="161768589" stop="163148833" display_start="161768589" display_stop="163148833" Strand="-" />
          </Location>
          <OMIM>602544</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_004562.2(PRKN):c.8-?_171+?del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6q26</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" innerStart="162443310" innerStop="162443473" display_start="162443310" display_stop="162443473" variantLength="164" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" innerStart="162864342" innerStop="162864505" display_start="162864342" display_stop="162864505" variantLength="164" />
      </Location>
      <OtherNameList>
        <Name>EX3DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004562.2" sequenceAccession="NM_004562" sequenceVersion="2" change="c.8-?_171+?del">
            <Expression>NM_004562.2:c.8-?_171+?del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.(?_162864342)_(162864505_?)del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.(?_162864342)_(162864505_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.(?_162443310)_(162443473_?)del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.(?_162443310)_(162443473_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="602544.0005" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">Deletion of exon 3 from gene PARK2.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004562.2(PRKN):c.8-?_171+?del AND Autosomal recessive juvenile Parkinson disease 2" Accession="RCV000007456" Version="11">
        <ClassifiedConditionList TraitSetID="1942">
          <ClassifiedCondition DB="MedGen" ID="C1868675">Autosomal recessive juvenile Parkinson disease 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-12-04" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-12-04" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2017-09-10" MostRecentSubmission="2022-12-31">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10072423</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17914726</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21993715</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22956510</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23880019</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9634531</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9802278</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301651</ID>
          <ID Source="BookShelf">NBK1478</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1942" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3274" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Parkinson disease, juvenile, type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkin Type of Juvenile Parkinson Disease</ElementValue>
                <XRef ID="NBK1478" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkin Type of Early-Onset Parkinson Disease</ElementValue>
                <XRef ID="NBK1478" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive juvenile Parkinson disease 2</ElementValue>
                <XRef ID="MONDO:0010820" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease, juvenile, autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease autosomal recessive, early onset</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Juvenile parkinsonism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease 2</ElementValue>
                <XRef ID="Parkinson+disease+2/9086" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinsonism, early onset, with diurnal fluctuation</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PDJ</ElementValue>
                <XRef Type="MIM" ID="600116" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">JP</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PARK2</ElementValue>
                <XRef Type="MIM" ID="600116" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9642" />
                <XRef ID="9642" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Parkin type of early-onset Parkinson disease (PARK-Parkin) is characterized by the cardinal signs of Parkinson disease (PD): bradykinesia, resting tremor, and rigidity. The median age at onset is 31 years (range: 3-81 years). The disease is slowly progressive: disease duration of more than 50 years has been reported. Clinical findings vary; hyperreflexia is common. Lower-limb dystonia may be a presenting sign and cognitive decline appears to be no more frequent than in the general population. Dyskinesia as a result of treatment with levodopa frequently occurs.</Attribute>
                <XRef ID="NBK1478" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301402</ID>
                <ID Source="BookShelf">NBK1223</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301651</ID>
                <ID Source="BookShelf">NBK1478</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS/MDS-ES, 2013">
                <ID Source="PubMed">23279440</ID>
              </Citation>
              <XRef ID="2828" DB="Orphanet" />
              <XRef ID="C1868675" DB="MedGen" />
              <XRef ID="MONDO:0010820" DB="MONDO" />
              <XRef Type="MIM" ID="600116" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1076840" SubmissionDate="2020-02-06" DateLastUpdated="2020-04-09" DateCreated="2015-10-11">
        <ClinVarSubmissionID localKey="3911870|MedGen:C1868675" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000563922" DateUpdated="2020-04-09" DateCreated="2015-10-11" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-12-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23880019</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10072423</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21993715</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20301651</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22956510</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17914726</ID>
          </Citation>
          <Comment>This variant is an out-of-frame deletion of the genomic region encompassing exon 2 of the PRKN gene. This is expected to create a premature translational stop signal and result in an absent or disrupted protein product. Similar deletions of exon 2 have been observed to be homozygous or in combination with another PRKN variant in many individuals affected with early-onset Parkinson's disease (PMID: 17914726, 21993715, 23880019). Loss-of-function variants in PRKN are known to be pathogenic (PMID: 10072423, 20301651, 22956510). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PARK2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.(?_162864342)_(162864505_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Parkinson disease 2</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C1868675" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6933794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="27656" SubmissionDate="2010-12-30" DateLastUpdated="2022-12-31" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="602544.0005_PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE" title="PRKN, EX3DEL_PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE" />
        <ClinVarAccession Accession="SCV000027656" DateUpdated="2022-12-31" DateCreated="2013-04-04" Type="SCV" Version="8" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1998-10-24">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">To determine the frequency of deletions in the PARK2 gene, Lucking et al. (1998) searched for homozygous deletions in the PARK2 gene in 12 PARK2-linked families with autosomal recessive juvenile parkinsonism (600116) and known or suspected consanguinity (a total of 32 patients). Five of the families originated from Italy, 4 from France, 1 from the Netherlands, 1 from Portugal, and 1 from Algeria. Six of the families had previously been reported by Tassin et al. (1998). They found 2 novel homozygous deletions in 8 patients from 3 families. The Algerian family carried a deletion of exons 8 and 9 (602544.0006). Deletions of exon 3 were found in 1 French and 1 Portuguese family. Deletions in the PARK2 gene accounted, therefore, for only a quarter of the PARK2-linked families with known or suspected consanguinity, which suggested that point mutations may be more prominent. Mean age at onset and clinical severity were similar in the deleted and nondeleted families. The overall clinical features were also similar, except that patients with exon 3 deletions had significantly lower frequencies of tremor than the nondeleted patients, a significantly later mean age at onset than those with exon 8-9 deletions, and a trend toward greater severity for similar disease durations. Both deletions were expected to cause frameshifts introducing a premature stop codon and resulting in truncated proteins with probable loss of function. The exon 3 deletion might have more harmful effects, leading to a shorter truncated protein, since these patients were more severely affected. The exon 8-9 deletion was, however, associated with earlier age at onset, as if the less truncated protein resulted in an additional toxic effect.</Attribute>
              <Citation>
                <ID Source="PubMed">9802278</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">9634531</ID>
              </Citation>
              <XRef DB="OMIM" ID="600116" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRKN" />
          </GeneList>
          <Name>PRKN, EX3DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">EX3DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="602544.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1076840" TraitType="Disease" MappingType="Name" MappingValue="Parkinson disease 2" MappingRef="Preferred">
        <MedGen CUI="C1868675" Name="Autosomal recessive juvenile Parkinson disease 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="27656" TraitType="Disease" MappingType="Name" MappingValue="PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE" MappingRef="Preferred">
        <MedGen CUI="C1868675" Name="Autosomal recessive juvenile Parkinson disease 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

